業績

{ 159件 }

Tsuneta S, Suno K, Fujieda Y, Watanabe M, Watanabe S, Hirata K, Nagai T, Kudo K.

Accumulation of Technetium-99m Tetrofosmin on Myocardial Perfusion Scintigraphy in a Patient With Immunoglobulin G4-Related Coronary Periarteritis Canadian Journal of Cardiology, in press

IF:6.2

  • 2024
  • 膠原病グループ
  • 欧文論文/原著

Mizui M, Kono M. Novel therapeutic strategies targeting abnormal T-cell signaling in systemic lupus erythematosus.

Clin Immunol. in press.

IF:8.6

  • 2024
  • 膠原病グループ
  • 邦文論文/総説

2024年度日本リウマチ学会 奨励賞 久田 諒先生

  • 2024
  • 膠原病グループ
  • 受賞

43回高桑榮松奨学基金奨励賞 久田 諒先生

  • 2024
  • 膠原病グループ
  • 受賞

Hirahara L, Kirino Y, Soejima Y, Iizuka Y, Yoshimi R, Fujieda Y, Atsumi T, Tono T, Kobayashi D, Meguro A, Takeuchi M, Sakamaki K, Takeno M, Mizuki N, Nakajima H Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Behçet disease: a prospective registry study Frontiers in Immunology, in press.

IF:7.3

  • 2024
  • 膠原病グループ
  • 欧文論文/原著

Nashimoto S, Miyamae M, Higuchi I, Kono M, Tada M, Atsumi T, Sugawara M, Takekuma Y.

Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report.

Case Reports in Nephrology and Dialysis. in press

IF=0.7

  • 2024
  • 膠原病グループ
  • 欧文論文/症例報告

Chighizola  CB, Willis R, Maioli G, Sciascia S, Andreoli L , Amengual O, Radin M , Gerosa M, Atsumi T, de Jesus G , Trespidi L , Branch DW , Caporali R, Andrade D, Roubey R , Petri M , Bertolaccini ML.

Deciphering the clinical significance of longitudinal antiphospholipid antibody titers.

Autoimmunity Reviews, in press

IF: 17.39

  • 2024
  • 膠原病グループ
  • 欧文論文/総説

Kato M, Kiuchi Y, Atsumi T, Furukawa S.

Vertebral involvement detected by tomosynthesis in SAPHO syndrome.

Rheumatology (Oxford). in press

IF=5.5

  • 2024
  • 膠原病グループ
  • 欧文論文/原著

10JCRベーシックリサーチカンファレンス ポスター賞 工藤 友喜さん

  • 2024
  • 膠原病グループ
  • 受賞

Sugawara M, Osanami A, Asai Y, Ogawa Y, Nagahata K, Nakamura H, Suzuki C, Kanda M, Takahashi H.

Successful treatment of ANCA-associated glomerulonephritis following pulmonary alveolar proteinosis by rituximab and avacopan.

Rheumatology, in press.

IF: 5.5

  • 2024
  • 膠原病グループ
  • 欧文論文/症例報告